IL6 and inflammatory bowel disease: The imbalance between pro- and anti-inflammatory cytokines (interleukin-6, tumor necrosis factor-alpha, etc.), oxidative DNA damage, and genomic instability have implications for colorectal carcinogenesis in IBD patients [23].